Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT

被引:4
作者
Gomez, Erin [1 ]
Tran, Phuoc T. [2 ]
Pienta, Kenneth J. [3 ,4 ]
Pomper, Martin G. [1 ,3 ,4 ]
Gorin, Michael A. [1 ,3 ,4 ]
Rowe, Steven P. [1 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St,Cent Radiol,Rm 118, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
prostate cancer; PSMA-targeted PET; hereditary spherocytosis; PSMA-RADS; F-18-DCFPyL;
D O I
10.1097/RLU.0000000000002489
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We present the case of a 71-year-old man with Gleason 3 + 3 = 6 pT2N0MxR0 adenocarcinoma of the prostate who presented with rising PSA level 16 years after radical prostatectomy. PSMA-targeted F-18-DCFPyL PET/CT was performed, which demonstrated recurrent disease in the prostatectomy bed as well as splenomegaly and mild-diffuse bone marrow activation, consistent with the patient's history of hereditary spherocytosis. We briefly review the clinical characteristics of hereditary spherocytosis, its appearance on molecular imaging studies, the normal biodistribution of F-18-DCFPyL, and the PSMA-RADS scoring system for characterizing findings on PSMA-targeted PET imaging.
引用
收藏
页码:E313 / E314
页数:2
相关论文
共 10 条
[1]   Radionuclide imaging of bone marrow disorders [J].
Agool, Ali ;
Glaudemans, Andor W. J. M. ;
Boersma, Hendrikus H. ;
Dierckx, Rudi A. J. O. ;
Vellenga, Edo ;
Slart, Riemer H. J. A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (01) :166-178
[2]   Old and new insights into the diagnosis of hereditary spherocytosis [J].
Ciepiela, Olga .
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (17)
[3]   Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders [J].
Da Costa, Lydie ;
Galimand, Julie ;
Fenneteau, Odile ;
Mohandas, Narla .
BLOOD REVIEWS, 2013, 27 (04) :167-178
[4]   Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0 [J].
Rowe, Steven P. ;
Pienta, Kenneth J. ;
Pomper, Martin G. ;
Gorin, Michael A. .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) :479-485
[5]  
Rowe SP, 2017, PET CLIN, V12, P289, DOI 10.1016/j.cpet.2017.02.006
[6]   Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging [J].
Sheikhbahaei, Sara ;
Afshar-Oromieh, Ali ;
Eiber, Matthias ;
Solnes, Lilja B. ;
Javadi, Mehrbod S. ;
Ross, Ashley E. ;
Pienta, Kenneth J. ;
Allaf, Mohamad E. ;
Haberkorn, Uwe ;
Pomper, Martin G. ;
Gorin, Michael A. ;
Rowe, Steven P. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) :2117-2136
[7]   Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer [J].
Szabo, Zsolt ;
Mena, Esther ;
Rowe, Steven P. ;
Plyku, Donika ;
Nidal, Rosa ;
Eisenberger, Mario A. ;
Antonarakis, Emmanuel S. ;
Fan, Hong ;
Dannals, Robert F. ;
Chen, Ying ;
Mease, Ronnie C. ;
Vranesic, Melin ;
Bhatnagar, Akrita ;
Sgouros, George ;
Cho, Steve Y. ;
Pomper, Martin G. .
MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) :565-574
[8]   PET in Benign Bone Marrow Disorders [J].
van der Bruggen, Wouter ;
Glaudemans, Andor W. J. M. ;
Vellenga, Edo ;
Slart, Riemer H. J. A. .
SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (04) :397-407
[9]   Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging [J].
Werner, Rudolf A. ;
Bundschuh, Ralph A. ;
Bundschuh, Lena ;
Javadi, Mehrbod S. ;
Leal, Jeffrey P. ;
Higuchi, Takahiro ;
Pienta, Kenneth J. ;
Buck, Andreas K. ;
Pomper, Martin G. ;
Gorin, Michael A. ;
Lapa, Constantin ;
Rowe, Steven P. .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (12) :1857-1864
[10]  
Yin Y, 2018, J NUCL MED